Shuai Lin

3.5k total citations
143 papers, 2.6k citations indexed

About

Shuai Lin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shuai Lin has authored 143 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 49 papers in Cancer Research and 40 papers in Oncology. Recurrent topics in Shuai Lin's work include Cancer-related molecular mechanisms research (19 papers), Breast Cancer Treatment Studies (13 papers) and RNA modifications and cancer (11 papers). Shuai Lin is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), Breast Cancer Treatment Studies (13 papers) and RNA modifications and cancer (11 papers). Shuai Lin collaborates with scholars based in China, United States and Hong Kong. Shuai Lin's co-authors include Zhijun Dai, Huafeng Kang, Xi-Jing Wang, Cong Dai, Peng Xu, Yujiao Deng, Pengtao Yang, Kang Liu, Yi Zheng and Xiaobin Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Shuai Lin

128 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuai Lin China 29 1.2k 582 500 320 294 143 2.6k
Weifeng Tang China 26 1.0k 0.9× 581 1.0× 493 1.0× 399 1.2× 435 1.5× 169 2.5k
Heng Zhang China 28 1.7k 1.4× 748 1.3× 436 0.9× 224 0.7× 320 1.1× 132 3.1k
Jie Gao China 32 2.1k 1.8× 944 1.6× 446 0.9× 408 1.3× 302 1.0× 88 3.3k
Juan Feng China 36 1.6k 1.3× 693 1.2× 449 0.9× 315 1.0× 723 2.5× 136 3.7k
Peng Xu China 24 709 0.6× 429 0.7× 489 1.0× 412 1.3× 168 0.6× 108 2.3k
Zhiyan Liu China 31 1.1k 0.9× 457 0.8× 494 1.0× 367 1.1× 214 0.7× 230 3.3k
Han Chen China 32 1.7k 1.4× 675 1.2× 279 0.6× 355 1.1× 159 0.5× 198 3.9k
Peizhan Chen China 26 794 0.7× 393 0.7× 644 1.3× 228 0.7× 501 1.7× 73 2.4k
Hong Cheng China 26 735 0.6× 340 0.6× 501 1.0× 339 1.1× 171 0.6× 137 2.5k
Yang Chen China 26 1.0k 0.9× 543 0.9× 965 1.9× 538 1.7× 243 0.8× 155 2.5k

Countries citing papers authored by Shuai Lin

Since Specialization
Citations

This map shows the geographic impact of Shuai Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Lin more than expected).

Fields of papers citing papers by Shuai Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Lin. The network helps show where Shuai Lin may publish in the future.

Co-authorship network of co-authors of Shuai Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Lin. A scholar is included among the top collaborators of Shuai Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Lin. Shuai Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Shuai, Yujun Zheng, Lexin Wang, et al.. (2025). Hydrogel contact lenses modified by quaternary chitosan and epigallocatechin gallate with enhancement of antimicrobial for bacterial keratitis. International Journal of Biological Macromolecules. 306(Pt 4). 141787–141787. 4 indexed citations
3.
Zhao, Ren, Chao He, Wei Jiang, Shuai Lin, & Yang Zhao. (2025). The Learning Curve of Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy with Immediate Prepectoral Implant Reconstruction: CUSUM Analysis. Breast Cancer Targets and Therapy. Volume 17. 1041–1050.
4.
Chu, Xiaoli, Shuting Tang, Guowei Wang, et al.. (2025). Personalized Medication for Chronic Diseases Using Multimodal Data‐Driven Chain‐of‐Decisions. Advanced Science. 12(40). e04079–e04079.
5.
Lin, Shuai, et al.. (2025). Burden and trends of diabetic kidney disease in East Asia, 1990–2038: An analysis of the global burden of disease study 2023. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 19(11). 103333–103333.
6.
Lin, Shuai, Shengjie Cui, Ran Zhang, et al.. (2025). Mechanical sensing protein PIEZO1 controls osteoarthritis via glycolysis mediated mesenchymal stem cells-Th17 cells crosstalk. Cell Death and Disease. 16(1). 231–231. 4 indexed citations
7.
Cao, Lin, Yue Zhou, Shuai Lin, et al.. (2024). The trajectory of vesicular proteomic signatures from HBV‐HCC by chitosan‐magnetic bead‐based separation and DIA‐proteomic analysis. Journal of Extracellular Vesicles. 13(9). e12499–e12499. 6 indexed citations
8.
Chen, Weiguo, et al.. (2024). A multifunctional CaCO3 bioreactor coated with coordination polymers enhances cancer immunotherapy. Journal of Controlled Release. 368. 780–796. 8 indexed citations
9.
Chen, Weiguo, et al.. (2024). Amorphous CaCO3-bioreactor for tumor microenvironment regulation to reinforce tumor chemoimmunotherapy. Chemical Engineering Journal. 490. 151838–151838. 8 indexed citations
10.
Xu, Peng, Zhangjian Zhou, Shuai Lin, et al.. (2024). Favorable outcome of neoadjuvant endocrine treatment than surgery‐first in female HR‐positive/HER2‐negative breast cancer patients—A NCDB analysis (2010–2016). Cancer Medicine. 13(11). e7244–e7244. 1 indexed citations
11.
Liu, Dandan, Qian Hao, Xueting Ren, et al.. (2024). Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancer. Journal of Cancer Research and Clinical Oncology. 150(8). 378–378.
12.
13.
Mao, Guochao, et al.. (2022). A Novel Glycolysis and Hypoxia Combined Gene Signature Predicts the Prognosis and Affects Immune Infiltration of Patients with Colon Cancer. SHILAP Revista de lepidopterología. 5 indexed citations
14.
Lin, Shuai, Xiaobin Ma, Peng Xu, et al.. (2022). Marsdenia tenacissima Extract Induces Autophagy and Apoptosis of Hepatocellular Cells via MIF/mToR Signaling. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 8 indexed citations
15.
Ren, Xueting, Nan Wang, Dandan Liu, et al.. (2022). Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer. Cancer Medicine. 11(20). 3886–3901. 16 indexed citations
16.
Zhou, Zhangjian, Shuai Lin, Xin Zhang, et al.. (2022). Prognostic effect of radiotherapy in breast cancer patients underwent immediate reconstruction after mastectomy. Frontiers in Oncology. 12. 1010088–1010088. 4 indexed citations
17.
Wang, Meng, Xinghan Liu, Shuai Lin, et al.. (2018). FABP1 Polymorphisms Contribute to Hepatocellular Carcinoma Susceptibility in Chinese Population with Liver Cirrhosis: A Case-Control Study. Journal of Cancer. 9(22). 4294–4300. 10 indexed citations
18.
Wang, Xiaolong, Lei Sun, Xi-Jing Wang, et al.. (2017). Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c‐Myc expression. Cancer Medicine. 6(4). 788–797. 32 indexed citations
19.
Ma, Xiaobin, Xi-Jing Wang, Meng Wang, et al.. (2016). Impact of the PARP1 rs1136410 and rs3219145 polymorphisms on susceptibility and clinicopathologic features of breast cancer in a Chinese population. Translational Cancer Research. 5(5). 520–528. 1 indexed citations
20.
Dai, Zhijun, Xi-Jing Wang, Yang Zhao, et al.. (2014). Effects of Interleukin-10 Polymorphisms (rs1800896, rs1800871, and rs1800872) on Breast Cancer Risk: Evidence from an Updated Meta-Analysis. Genetic Testing and Molecular Biomarkers. 18(6). 439–445. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weifeng Tang Breakdown of academic impact, for papers by Heng Zhang Breakdown of academic impact, for papers by Jie Gao Breakdown of academic impact, for papers by Juan Feng Breakdown of academic impact, for papers by Peng Xu Breakdown of academic impact, for papers by Zhiyan Liu Breakdown of academic impact, for papers by Han Chen Breakdown of academic impact, for papers by Peizhan Chen Breakdown of academic impact, for papers by Hong Cheng Breakdown of academic impact, for papers by Yang Chen
Rankless by CCL
2026